Genetic variants in genes related to lipid metabolism and atherosclerosis, dyslipidemia and atorvastatin response (2013)
- Authors:
- Rodrigues, Alice Cristina
- Sobrino, B
- Genvigir, Fabiana Dalla Vecchia
- Willrich, Maria Alice Vieira
- Arazi, Simone Sorkin
- Dórea, Egidio Lima
- Bernik, Marcia Martins Silveira
- Bertolami, Marcelo - Instituto Dante Pazzanese de Cardiologia (IDPC)
- Faludi, André Arpad - Instituto Dante Pazzanese de Cardiologia (IDPC)
- Brion, M. J
- Carracedo, Angel
- Hirata, Mario Hiroyuki
- Hirata, Rosario Dominguez Crespo
- USP affiliated authors: DOREA, EGIDIO LIMA - HU ; HIRATA, MARIO HIROYUKI - FCF ; HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF
- Unidades: HU; FCF
- DOI: 10.1016/j.cca.2012.11.028
- Subjects: DISLIPIDEMIAS; ARTERIOSCLEROSE
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Clinica Chimica Acta
- ISSN: 0009-8981
- Volume/Número/Paginação/Ano: v. 417, n. 1, p. 8-11, 2013
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
RODRIGUES, Alice Cristina et al. Genetic variants in genes related to lipid metabolism and atherosclerosis, dyslipidemia and atorvastatin response. Clinica Chimica Acta, v. 417, n. 1, p. 8-11, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.cca.2012.11.028. Acesso em: 19 abr. 2024. -
APA
Rodrigues, A. C., Sobrino, B., Genvigir, F. D. V., Willrich, M. A. V., Arazi, S. S., Dórea, E. L., et al. (2013). Genetic variants in genes related to lipid metabolism and atherosclerosis, dyslipidemia and atorvastatin response. Clinica Chimica Acta, 417( 1), 8-11. doi:10.1016/j.cca.2012.11.028 -
NLM
Rodrigues AC, Sobrino B, Genvigir FDV, Willrich MAV, Arazi SS, Dórea EL, Bernik MMS, Bertolami M, Faludi AA, Brion MJ, Carracedo A, Hirata MH, Hirata RDC. Genetic variants in genes related to lipid metabolism and atherosclerosis, dyslipidemia and atorvastatin response [Internet]. Clinica Chimica Acta. 2013 ; 417( 1): 8-11.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1016/j.cca.2012.11.028 -
Vancouver
Rodrigues AC, Sobrino B, Genvigir FDV, Willrich MAV, Arazi SS, Dórea EL, Bernik MMS, Bertolami M, Faludi AA, Brion MJ, Carracedo A, Hirata MH, Hirata RDC. Genetic variants in genes related to lipid metabolism and atherosclerosis, dyslipidemia and atorvastatin response [Internet]. Clinica Chimica Acta. 2013 ; 417( 1): 8-11.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1016/j.cca.2012.11.028 - Relationships among CYP3A4 and CYP3A5 haplotypes, mRNA expression, CYP3A activity and atorvastatin response in hypercholesterolemic individuals
- Differentiation of african components of ancestry to stratify groups in a case-control study of a brazilian urban population
- Influence of SCARB1 polymorphisms on serum lipids of hypercholesterolemic individuals treated with atorvastatin
- Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression
- The contribution of genetic polymorphisms in 60 candidate genes to variability in atorvastatin response
- CYP3A5*3A allele is associated with reduced lowering-lipid response to atorvastatin in individuals with hypercholesterolemia
- Effects of atorvastatin on CYP3A4 and CYP3A5 mRNA expression in mononuclear cells and CYP3A activity in hypercholeresterolemic patients
- Pharmacogenetics of OATP transporters reveals that SLCO1B1 c.388A>G variant is determinant of increased atorvastatin response
- Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression
- Apolipoprotein E mRNA expression in mononuclear cells from normolipidemic and hypercholesterolemic individuals treated with atorvastatin
Informações sobre o DOI: 10.1016/j.cca.2012.11.028 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas